1
|
Knudsen LB. Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity. ACS Pharmacol Transl Sci 2019; 2:468-484. [PMID: 32259078 DOI: 10.1021/acsptsci.9b00048] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2019] [Indexed: 01/08/2023]
Abstract
Glucagon-like peptide-1 (GLP-1) has been in focus since the early 1980s as a long looked for incretin hormone, released from the gastrointestinal tract and with an important effect on glucose-dependent insulin secretion, providing efficient glucose lowering, with little risk for hypoglycemia. The enzyme dipeptidyl peptidase-4 (DPP-4) degrades GLP-1 very fast, and the remaining metabolite is cleared rapidly by the kidneys. Liraglutide is a fatty acid acylated analogue of GLP-1 that provides efficacy for 24 h/day. The mechanism of action for liraglutide is reviewed in detail with focus on pancreatic efficacy and safety, thyroid safety, and weight loss mechanism. Evolving science hypothesizes that GLP-1 has important effects on atherosclerosis, relevant for the cardiovascular benefit seen in the treatment of diabetes and obesity. Also, GLP-1 may be relevant in neurodegenerative diseases.
Collapse
Affiliation(s)
- Lotte Bjerre Knudsen
- Global Drug Discovery, Novo Nordisk, Novo Nordisk Park, DK-2760 Maaloev, Denmark
| |
Collapse
|
2
|
Brändli-Baiocco A, Balme E, Bruder M, Chandra S, Hellmann J, Hoenerhoff MJ, Kambara T, Landes C, Lenz B, Mense M, Rittinghausen S, Satoh H, Schorsch F, Seeliger F, Tanaka T, Tsuchitani M, Wojcinski Z, Rosol TJ. Nonproliferative and Proliferative Lesions of the Rat and Mouse Endocrine System. J Toxicol Pathol 2018; 31:1S-95S. [PMID: 30158740 PMCID: PMC6108091 DOI: 10.1293/tox.31.1s] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
The INHAND (International Harmonization of Nomenclature and Diagnostic Criteria for
Lesions in Rats and Mice) Project (www.toxpath.org/inhand.asp) is a joint initiative among
the Societies of Toxicological Pathology from Europe (ESTP), Great Britain (BSTP), Japan
(JSTP) and North America (STP) to develop an internationally accepted nomenclature for
proliferative and nonproliferative lesions in laboratory animals. The purpose of this
publication is to provide a standardized nomenclature for classifying microscopic lesions
observed in the endocrine organs (pituitary gland, pineal gland, thyroid gland,
parathyroid glands, adrenal glands and pancreatic islets) of laboratory rats and mice,
with color photomicrographs illustrating examples of the lesions. The standardized
nomenclature presented in this document is also available electronically on the internet
(http://www.goreni.org/). Sources of material included histopathology databases from
government, academia, and industrial laboratories throughout the world. Content includes
spontaneous and aging lesions as well as lesions induced by exposure to test materials. A
widely accepted and utilized international harmonization of nomenclature for endocrine
lesions in laboratory animals will decrease confusion among regulatory and scientific
research organizations in different countries and provide a common language to increase
and enrich international exchanges of information among toxicologists and
pathologists.
Collapse
Affiliation(s)
- Annamaria Brändli-Baiocco
- Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland
| | | | - Marc Bruder
- Compugen, Inc., Nonclinical Safety, South San Francisco, California, USA
| | | | | | - Mark J Hoenerhoff
- In Vivo Animal Core, Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, Michigan USA
| | | | - Christian Landes
- Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland
| | - Barbara Lenz
- Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland
| | | | | | - Hiroshi Satoh
- Iwate University, Faculty of Agriculture, Iwate, Japan
| | | | - Frank Seeliger
- AstraZeneca Pathology, Drug Safety and Metabolism, IMED Biotech Unit, Gothenburg, Sweden
| | - Takuji Tanaka
- Tohkai Cytopathology Institute, Cancer Research and Prevention, Gifu, Japan
| | - Minoru Tsuchitani
- LSI Medience Corporation, Nonclinical Research Center, Ibaraki, Japan
| | | | - Thomas J Rosol
- Ohio University, Department of Biomedical Sciences, Athens, Ohio, USA
| |
Collapse
|
3
|
Adams TB, McGowen MM, Williams MC, Cohen SM, Feron VJ, Goodman JI, Marnett LJ, Munro IC, Portoghese PS, Smith RL, Waddell WJ. The FEMA GRAS assessment of aromatic substituted secondary alcohols, ketones, and related esters used as flavor ingredients. Food Chem Toxicol 2007; 45:171-201. [PMID: 17046133 DOI: 10.1016/j.fct.2006.07.029] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2006] [Revised: 07/12/2006] [Accepted: 07/20/2006] [Indexed: 11/17/2022]
Abstract
This publication is the 11th in a series of safety evaluations performed by the Expert Panel of the Flavor and Extract Manufacturers Association (FEMA). In 1993, the Panel initiated a comprehensive program to re-evaluate the safety of more than 1700 GRAS flavoring substances under conditions of intended use. The list of GRAS substances has now grown to more than 2100 substances. Elements that are fundamental to the safety evaluation of flavor ingredients include exposure, structural analogy, metabolism, pharmacokinetics and toxicology. Flavor ingredients are evaluated individually and in the context of the available scientific information on the group of structurally related substances. In this monograph, a detailed interpretation is presented on the renal carcinogenic potential of the aromatic secondary alcohol alpha-methylbenzyl alcohol, aromatic ketone benzophenone, and corresponding alcohol benzhydrol. The relevance of these effects to the flavor use of these substances is also discussed. The group of aromatic substituted secondary alcohols, ketones, and related esters was reaffirmed as GRAS (GRASr) based, in part, on their rapid absorption, metabolic detoxication, and excretion in humans and other animals; their low level of flavor use; the wide margins of safety between the conservative estimates of intake and the no-observed-adverse effect levels determined from subchronic and chronic studies and the lack of significant genotoxic and mutagenic potential.
Collapse
Affiliation(s)
- T B Adams
- Flavor and Extract Manufacturers Association, 1620 I Street, NW, Suite 925, Washington, DC 20006, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Boorman GA, McCormick DL, Findlay JC, Hailey JR, Gauger JR, Johnson TR, Kovatch RM, Sills RC, Haseman JK. Chronic toxicity/oncogenicity evaluation of 60 Hz (power frequency) magnetic fields in F344/N rats. Toxicol Pathol 1999; 27:267-78. [PMID: 10356702 DOI: 10.1177/019262339902700301] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
A 2-yr whole-body exposure study was conducted to evaluate the chronic toxicity and possible oncogenicity of 60 Hz (power frequency) magnetic fields in rats. Groups of 100 male and 100 female F344/N rats were exposed continuously to pure, linearly polarized, transient-free 60 Hz magnetic fields at flux densities of 0 Gauss (G) (sham control), 20 milligauss (mG), 2 G, and 10 G; an additional group of 100 male and 100 female F344/N rats received intermittent (1 hr on/1 hr off) exposure to 10 G fields. Mortality patterns, body weight gains throughout the study, and the total incidence and number of malignant and benign tumors in all groups exposed to magnetic fields were similar to those found in sex-matched sham controls. Statistically significant increases in the combined incidence of C-cell adenomas and carcinomas of the thyroid were seen in male rats chronically exposed to 20 mG and 2 G magnetic fields. These increases were not seen in male rats exposed continuously or intermittently to 10 G fields or in female rats at any magnetic field exposure level. No increases in the incidence of neoplasms, which have been identified in epidemiology studies as possible targets of magnetic field action (leukemia, breast cancer, and brain cancer), were found in any group exposed to magnetic fields. There was a decrease in leukemia in male rats exposed to 10 G intermittent fields. The occurrence of C-cell tumors at the 2 lower field intensities in male rats is interpreted as equivocal evidence of carcinogenicity; data from female rats provides no evidence of carcinogenicity in that sex. These data, when considered as a whole, are interpreted as indicating that chronic exposure to pure linearly polarized 60 Hz magnetic fields has little or no effect on cancer development in the F344/N rat.
Collapse
MESH Headings
- Adenoma/etiology
- Adenoma/mortality
- Adenoma/pathology
- Animals
- Body Weight/radiation effects
- Carcinoma, Medullary/etiology
- Carcinoma, Medullary/mortality
- Carcinoma, Medullary/pathology
- Electromagnetic Fields/adverse effects
- Evaluation Studies as Topic
- Female
- Fibroadenoma/etiology
- Fibroadenoma/mortality
- Fibroadenoma/pathology
- Leukemia, Radiation-Induced/etiology
- Leukemia, Radiation-Induced/mortality
- Leukemia, Radiation-Induced/pathology
- Male
- Mammary Neoplasms, Animal/etiology
- Mammary Neoplasms, Animal/mortality
- Mammary Neoplasms, Animal/pathology
- Neoplasms, Radiation-Induced/etiology
- Neoplasms, Radiation-Induced/mortality
- Neoplasms, Radiation-Induced/pathology
- Radiation Injuries, Experimental/etiology
- Radiation Injuries, Experimental/mortality
- Radiation Injuries, Experimental/pathology
- Rats
- Rats, Inbred F344
- Sex Factors
- Survival Rate
- Thyroid Neoplasms/etiology
- Thyroid Neoplasms/mortality
- Thyroid Neoplasms/pathology
- Whole-Body Irradiation
Collapse
Affiliation(s)
- G A Boorman
- National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|